Organ-on-Chip Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Offering, By Material Type, By Application, By End User, By Region & Competition, 2020-2030F
상품코드:1785184
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 장기칩 시장은 2024년에는 4억 6,757만 달러로 평가되었고 예측 기간에는 2030년까지 연평균 복합 성장률(CAGR) 25.61%를 나타내 눈부신 성장을 이룰 것으로 예상되고 있습니다.
장기칩은 인간의 장기를 정교하게 재현한 인공 장기입니다. 이러한 최첨단 장치는 멀티채널 3D 마이크로플루이딕스 세포 배양 기술을 활용하여 장기의 기능, 프로세스 및 생리적 반응을 충실히 모방합니다. 실험실 칩(LOC)을 세포 생물학과 결합하여 연구자들은 체외 다세포 인간의 새로운 모델을 성공적으로 만들고 장기 특이적인 환경에서 인간 생리학을 분석 할 수 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
4억 6,757만 달러
시장 규모 : 2030년
18억 400만 달러
CAGR : 2025-2030년
25.61%
급성장 부문
제약 및 생명공학 기업
최대 시장
북미
이 칩은 혈액과 공기의 흐름을 촉진하도록 복잡하게 설계된 마이크로채널을 특징으로 하며 폐, 장, 뇌, 간, 심장 등 다양한 기관의 시뮬레이션을 가능하게 합니다. 마이크로칩에는 살아있는 세포가 배치되어 끊임없는 관류에 의해 조직이나 장기의 기능을 키웁니다. 장기칩 기술은 실리콘 영양, 조직 공학, 미세 유체 공학을 독자적으로 융합시킨 것으로, 이 분야에 혁명을 일으킬 가능성을 가지고 있습니다. 이러한 진보는 창약과 질병 치료에 있어서 오랜 과제에 대한 대응에 큰 기대를 안겨, 의약품 개발 조사에 있어서 중요한 요소가 되어 장기칩 업계를 전진시킵니다.
주요 시장 성장 촉진요인
전자칩의 소형화 수요 증가
주요 시장 과제
장기칩 장치의 높은 비용으로 우려
주요 시장 동향
시장개발 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 장기칩 시장 전망
시장 규모와 예측
금액별
시장 점유율·예측
유형별(간, 심장, 폐, 신장, 기타)
제공별(제품 대 서비스)
재료 유형별(폴리머, PDMS, 유리, 실리콘, 기타)
용도별(생리학적 모델 개발, 신약 개발, 독성학 연구, 분자생물학, 기타)
최종 사용자별(제약 및 생명공학 기업, 학술 및 연구 기관, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 장기칩 시장 전망
시장 규모와 예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 장기칩 시장 전망
시장 규모와 예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 장기칩 시장 전망
시장 규모와 예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 장기칩 시장 전망
시장 규모와 예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 장기칩 시장 전망
시장 규모와 예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 출시
제13장 세계의 장기칩 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Altis Biosystems
AxoSim Inc.
BiomimX SRL
Emulate Inc.
Hesperos
Allevi Inc.
InSphero AG
MIMETAS BV
Nortis Inc.
Hesperos, Inc.
제16장 전략적 제안
제17장 기업 소개와 면책사항
KTH
영문 목차
영문목차
Global Organ-on-Chip Market was valued at USD 467.57 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 25.61% through 2030. Organs-on-chip are sophisticated artificial replicas of human organs. These cutting-edge devices utilize multichannel 3D microfluidic cell culture technology to faithfully mimic organ functions, processes, and physiological responses. By combining labs-on-chips (LOCs) with cell biology, researchers have successfully created a novel model of in vitro multicellular human beings, allowing for the analysis of human physiology within organ-specific environments.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 467.57 Million
Market Size 2030
USD 1804.00 Million
CAGR 2025-2030
25.61%
Fastest Growing Segment
Pharmaceutical & Biotechnology Companies
Largest Market
North America
These chips feature intricately designed microchannels that facilitate blood and air flow, enabling the simulation of various organs such as the lung, intestine, brain, liver, and heart. The microchips are populated with live cells, fostering tissue and organ function through constant perfusion. Organ-on-chip technology, with its unique blend of silicone nourishment, tissue engineering, and microfluidics, has the potential to revolutionize the field. These advancements hold great promise in addressing longstanding challenges in drug discovery and disease treatment, making it a crucial component in drug development investigations and propelling the organ-on-chip industry forward.
Key Market Drivers
Growing Demand of Miniaturization of Electronic Chips
The growing prevalence for microchips in the field of medical devices is a direct result of remarkable technological advancements. These advancements have not only fueled the demand for such devices but also paved the way for significant improvements in their construction and maintenance. The process of miniaturization has played a key role in achieving these advancements, as it allows for the reduction of materials required to build and sustain the system.
Moreover, the utilization of microfluidic chips has revolutionized the development of miniaturized tissues, enabling the simulation of real tissue in organ-on-a-chip systems. By creating an in vitro environment at the microscopic scale, these microfluidic chips effectively mimic the function and structure of actual organs. This breakthrough technology holds tremendous promise in advancing our understanding of organ function and disease progression. The integration of microchips and microfluidic chips in medical devices marks a significant milestone in the field of healthcare. With continued research and innovation, we can expect even greater advancements in this fascinating area, ultimately leading to improved diagnostics, treatments, and overall patient care.
Key Market Challenges
Concerns Pertaining due to High Cost of Organ Chip Device
The high cost associated with the organ chip device, coupled with the fact that organ-on-chip (OOC) technology is still in its early stages, is projected to limit the expansion of the market. This is primarily due to the significant investment required for research and development, manufacturing, and commercialization of organ-on-chip devices. The complex nature of the technology, involving the integration of multiple organ models and microfluidic systems, adds to the manufacturing challenges and cost considerations.
Furthermore, certain countries have imposed restrictions on cosmetic testing on animals, which is likely to further hinder the growth of the global organ-on-chip market. In these countries, the government has prohibited the use of animals for testing cosmetics developed within their borders, reflecting a growing awareness and concern for animal welfare. This shift in regulatory policies has prompted the need for alternative testing methods, such as organ-on-chip technology, which can simulate the physiological conditions of human organs and provide more accurate and ethical results.
These factors collectively contribute to the complex landscape surrounding the adoption and market potential of organ-on-chip technology. While the technology holds great promise for revolutionizing drug discovery, toxicity testing, and personalized medicine, overcoming the barriers of cost, scale-up, and regulatory requirements remains crucial for its widespread adoption and market success. Continued advancements in technology, coupled with collaborative efforts between academia, industry, and regulatory bodies, will play a vital role in addressing these challenges and unlocking the full potential of organ-on-chip technology in improving healthcare outcomes.
Key Market Trends
Increasing Market Developments
The organ-on-chip market is witnessing significant growth largely driven by a series of strategic market developments such as product launches, collaborations, mergers, and acquisitions. Companies in this space are continuously innovating by launching new organ-on-chip devices that more accurately mimic human organs and their functions. These innovations not only improve the reliability and efficiency of the technology but also expand its applications across various fields including drug discovery, toxicology testing, and personalized medicine. As new products emerge, they attract a broader range of customers, which helps drive the overall market expansion.
Collaborations between biotech firms, pharmaceutical companies, and research institutions are playing a crucial role in accelerating the development and commercialization of organ-on-chip technologies. By combining expertise and resources, these partnerships help in speeding up research, validating new models, and entering new markets. Additionally, collaborations often enable sharing of high-cost resources and access to advanced technology platforms, which further promotes innovation and market penetration.
Mergers and acquisitions are also key drivers of growth in the organ-on-chip market. Larger companies are acquiring smaller startups that have developed innovative technologies, allowing them to quickly integrate new capabilities and expand their product portfolios. These consolidations provide companies with enhanced financial and technical resources, enabling more substantial investments in research and marketing. Moreover, such activities help strengthen competitive positioning and broaden the reach of organ-on-chip solutions.
Another important factor fueling market growth is increased funding from venture capital, government grants, and other investors. This influx of capital supports further innovation, clinical validation, and regulatory approval processes, all of which are critical to bringing advanced organ-on-chip products to market. In parallel, regulatory agencies are gradually recognizing the value of organ-on-chip platforms as alternatives to traditional animal testing, which has encouraged adoption by reducing barriers related to compliance and ethical concerns.
Key Market Players
Altis Biosystems
AxoSim Inc.
BiomimX SRL
Emulate Inc.
Hesperos
Allevi Inc.
InSphero AG
MIMETAS BV
Nortis Inc.
Hesperos, Inc.
Report Scope:
In this report, the Global Organ-on-Chip Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Organ-on-Chip Market, By Type:
Liver
Heart
Lung
Kidney
Others
Organ-on-Chip Market, By Offering:
Products
Services
Organ-on-Chip Market, By Material Type:
Polymer
PDMS
Glass
Silicon
Others
Organ-on-Chip Market, By Application:
Physiological Model Development
Drug Discovery
Toxicological Research
Molecular Biology
Others
Organ-on-Chip Market, By End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Organ-on-Chip Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Organ-on-Chip Market.
Available Customizations:
Global Organ-on-Chip market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Organ-on-Chip Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Liver, Heart, Lung, Kidney, Others)
5.2.2. By Offering (Products v/s Services)
5.2.3. By Material Type (Polymer, PDMS, Glass, Silicon, Others)
5.2.4. By Application (Physiological Model Development, Drug Discovery, Toxicological Research, Molecular Biology, Others)
5.2.5. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. North America Organ-on-Chip Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Offering
6.2.3. By Material Type
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Organ-on-Chip Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Offering
6.3.1.2.3. By Material Type
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Organ-on-Chip Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Offering
6.3.2.2.3. By Material Type
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Organ-on-Chip Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Offering
6.3.3.2.3. By Material Type
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Organ-on-Chip Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Offering
7.2.3. By Material Type
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Organ-on-Chip Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Offering
7.3.1.2.3. By Material Type
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. United Kingdom Organ-on-Chip Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Offering
7.3.2.2.3. By Material Type
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Italy Organ-on-Chip Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Offering
7.3.3.2.3. By Material Type
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. France Organ-on-Chip Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Offering
7.3.4.2.3. By Material Type
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Organ-on-Chip Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Offering
7.3.5.2.3. By Material Type
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia-Pacific Organ-on-Chip Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Offering
8.2.3. By Material Type
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Organ-on-Chip Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Offering
8.3.1.2.3. By Material Type
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Organ-on-Chip Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Offering
8.3.2.2.3. By Material Type
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Organ-on-Chip Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Offering
8.3.3.2.3. By Material Type
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Organ-on-Chip Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Offering
8.3.4.2.3. By Material Type
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Organ-on-Chip Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Offering
8.3.5.2.3. By Material Type
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. South America Organ-on-Chip Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Offering
9.2.3. By Material Type
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Organ-on-Chip Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Offering
9.3.1.2.3. By Material Type
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Organ-on-Chip Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Offering
9.3.2.2.3. By Material Type
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Organ-on-Chip Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Offering
9.3.3.2.3. By Material Type
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Middle East and Africa Organ-on-Chip Market Outlook
